According to the provisions of Article 28 of the Social Insurance Law of People's Republic of China (PRC), medical expenses that meet the basic medical insurance drug list, diagnosis and treatment items, medical service facilities standards and emergency rescue shall be paid from the basic medical insurance fund in accordance with state regulations, that is, Ningbo has medical insurance for hepatitis B virus resistance, but it is generally impossible to fully reimburse it when it is treated.

The treatment fee for hepatitis B virus in Ningbo is reimbursed by medical insurance, but only if you have participated in rural cooperative medical insurance, that is to say, you can only reimburse the treatment fee for hepatitis B if you have participated in rural cooperative medical insurance. There is also a long-acting interferon for treating hepatitis B, which can be reimbursed, but the course of treatment is limited. Oral nucleoside analogues of lamivudine, telbivudine and entecavir can be reimbursed.